Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Ecancermedicalscience|September 26, 2022
Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumoursJoão Glasberg, Aley Talans, Thomás Rivelli Giollo, et al.
Ecancermedicalscience|June 10, 2022
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumoursJoão Glasberg, Aley Talans, Thomás Rivelli Giollo, et al.
Nuclear Medicine Communications|January 31, 2018
Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancerMaria I Braghiroli, José M Mota, Paulo S Duarte, et al.
Cancer|July 16, 2024
Update in the management of gastroenteropancreatic neuroendocrine tumorsAndrew J H Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Scientific Reports|March 19, 2021
Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, BrazilVictor Hugo Fonseca de Jesus, Wilson Luiz da Costa, Laura Carolina Lopez Claro, et al.
Clinical Colorectal Cancer|October 10, 2018
Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal CancerManuela Vasconcelos Castro Sales, Claudia K Suemoto, Daniel Apolinario, et al.
Ecancermedicalscience|April 8, 2020
Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysisTiago Cordeiro Felismino, Victor Hugo Fonseca de Jesus, Bruno Cezar de Mendonça Uchóa Junior, et al.
Clinical Colorectal Cancer|June 19, 2023
Effects of Palliative Chemotherapy in Unresectable or Metastatic Colorectal Cancer Patients With Poor Performance StatusLucila Soares da Silva Rocha, Camila Motta Venchiarutti Moniz, Marilia Polo Mingueti E Silva, et al.
Ecancermedicalscience|April 28, 2023
Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapySamara T Pacheco, Mauro D Donadio, Felipe Almeida, et al.
Neuroendocrinology|May 14, 2020
Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World PatientsCarine Mauro, Victor Hugo Fonseca de Jesus, Milton Barros, et al.
Pageof 10